ClinicalTrials.gg
RecruitingNCT07944833Updated Nov 18, 2026

Mechanical Characterization of Vestibular Schwannoma: Classification Based on Magnetic Resonance Elastography and Its Clinical Relevance Study

An observational study in Vestibular Schwannoma, sponsored by Shengjing Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Shengjing Hospital · Observational

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
40
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Neuroma, Acoustic with a site in China — 7 open to participants now, 7 under way, 1 of them phase 3. Neuroma, Acoustic · China.

Started
2026
with 4 others
Observational
2 of 10
2 open now
Registered
10th of 10
by date
Lead sponsor
2 of 10
Shengjing Hospital

Among the 10 studies in Neuroma, Acoustic with a site in China, this one is one of 5 that started in 2026, is one of 2 observational ones, and was the 10th registered.

Neuroma, Acoustic

101 studies on the registry are indexed under Neuroma, Acoustic; 29 are open to participants now.

Browse Neuroma, Acoustic studies →

Open to participants now

7 of the 10 studies in Neuroma, Acoustic with a site in China are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 23 Neuroma, Acoustic studies recruiting now, 9 (39%) set no upper age limit and 9 (39%) stop at 75 or younger; 3 take children under 18; 4 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Neuroma, Acoustic with a site in China, or all of them as a file.
02

Study summary

This retrospective study aims at investigating the value of preoperative magnetic resonance elastography (MRE) in assessing the biomechanical characteristics of vestibular schwannomas and predicting surgical risk. Tumor stiffness and three-dimensional adhesion characteristics will be quantitatively analyzed and correlated with clinical parameters, including intraoperative tumor consistency and adhesion severity, operative time, blood loss, and postoperative neurological function. The study aims to validate the associations between MRE-derived imaging parameters, intraoperative findings, and clinical outcomes, thereby providing an imaging-based foundation for preoperative risk assessment and individualized surgical planning for vestibular schwannomas.

Read the detailed description

Vestibular schwannomas exhibit considerable variability in tumor stiffness and adhesion to surrounding tissues, which may influence surgical complexity, the extent of resection, and postoperative neurological recovery. Conventional magnetic resonance imaging (MRI) provides information on tumor morphology and its anatomical relationships with adjacent structures; however, it remains limited in quantitatively characterizing intratumoral stiffness and three-dimensionally assessing adhesion characteristics at the tumor interface. This study aims to systematically evaluate the ability of magnetic resonance elastography to quantitatively characterize the biomechanical properties of vestibular schwannomas and explore its clinical utility in preoperative surgical risk stratification.

All participants will undergo conventional preoperative MRI and MRE examinations. Relevant clinical data, including hearing status and facial nerve function, will also be collected. Post-processing of MRE images will be performed to extract quantitative parameters reflecting tumor stiffness and generate stiffness distribution maps across different tumor regions. In addition, three-dimensional sliding interface imaging-related techniques will be used to characterize adhesion features at the interface between the tumor and adjacent tissues, enabling a comprehensive assessment of spatial heterogeneity in tumor stiffness and the biomechanical properties of tissue interfaces.During surgery, intraoperative findings, including tumor consistency, adhesion severity, operative time, intraoperative blood loss, and extent of tumor resection, will be systematically documented. Postoperative facial nerve function, hearing outcomes, and relevant histopathological data will also be collected.

Statistical analyses will be selected according to the nature of the outcome variables and will include correlation analyses, regression analyses, and receiver operating characteristic (ROC) curve analyses to evaluate the diagnostic performance of MRE parameters and their associations with surgical outcomes. The potential predictive value of tumor stiffness and adhesion characteristics for clinical outcomes, particularly postoperative facial nerve function, will be further explored. This study aims to establish an integrated framework linking preoperative quantitative imaging measurements with intraoperative biomechanical findings and postoperative clinical outcomes, thereby providing an imaging-based foundation for preoperative risk assessment, and individualized clinical decision-making in patients with vestibular schwannomas.

03

Conditions studied

  • Vestibular Schwannoma

Browse trials for

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study will enroll adult patients with unilateral sporadic vestibular schwannoma who are scheduled to undergo microsurgical resection at Shengjing hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-All patients undergoing vestibular schwannoma resection surgery are eligible for inclusion in the study cohort.

Exclusion criteria

Exclusion Criteria:

  • Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who can not remove dentures, insulin pumps, or rings)
  • Pregnant women in the first trimester (within three months)
  • Patients with severe claustrophobia or anxiety
  • Patients with severe fever
  • Patients who can not tolerate MRE
  • Patients with vascular malformations and aneurysms.
  • Patients who do not sign an
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • MRE group

    Participants will undergo preoperative magnetic resonance elastography . Quantitative tumor stiffness parameters will be derived through image post-processing, and a three-dimensional map of tumor adhesion characteristics will be generated. MRE-derived imaging parameters will be analyzed in relation to intraoperative findings, including tumor consistency, adhesion severity, operative time, blood loss, and extent of resection. Postoperative facial nerve function, hearing outcomes, and relevant histopathological data will also be collected to evaluate the potential predictive value of MRE parameters for surgical risk and clinical outcomes.

06

What researchers measure

Primary outcomes

  1. Association of Preoperative MRE-Derived Quantitative Parameters With Intraoperative Tumor Consistency and Adhesion Severity

    Quantitative tumor stiffness parameters and three-dimensional adhesion characteristics derived from preoperative magnetic resonance elastography will be analyzed and compared with intraoperative assessments of tumor consistency and adhesion severity. The ability of MRE-derived parameters to characterize the biomechanical properties of vestibular schwannomas will be evaluated. Correlation analyses and, where appropriate, receiver operating characteristic (ROC) curve analyses will be performed to assess the associations and discriminative performance of imaging parameters in relation to intraoperative findings.

    Time frame: From preoperative MRE examination to surgery; intraoperative assessments will be performed during tumor resection.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Yin Z, Glaser KJ, Manduca A, Van Gompel JJ, Link MJ, Hughes JD, Romano A, Ehman RL, Huston J 3rd. Slip Interface Imaging Predicts Tumor-Brain Adhesion in Vestibular Schwannomas. Radiology. 2015 Nov;277(2):507-17. doi: 10.1148/radiol.2015151075. Epub 2015 Aug 6. PubMed 26247776 ↗
  • Cheng W, Bai S, Zeng Y, Zheng K, Hong Y, Han S, Zhang T, Guo M, Liu T, Wu J, Manduca A, Huston Iii J, Sheng Y, Wu Q, Jiao N, Yin Z, Shi Y, Wu A. Magnetic resonance elastography characterization of meningioma mechanical properties for improved neurosurgical planning and resection a prospective cohort study. Int J Surg. 2025 Dec 11. doi: 10.1097/JS9.0000000000004199. Online ahead of print. PubMed 41376349 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2026 (actual). Primary completion is estimated for Feb 2027, 5 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 18, 2026
StartActual
Aug 10, 2026
Primary completionEst.
Feb 1, 2027
CompletionEst.
Feb 1, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07944833
Lead sponsor
Shengjing Hospital
Responsible party
Anhua Wu (Professor, Shengjing Hospital) — Principal investigator
First posted
Nov 18, 2026
Start date
Aug 10, 2026
Primary completion
Feb 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

wen Cheng
Contact
cmu071207@163.com
18940250139

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion